| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.3 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |